KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cigna (CI) Notes Payables (2017 - 2019)

Cigna (CI) has disclosed Notes Payables for 3 consecutive years, with $944.0 million as the latest value for Q4 2019.

  • Quarterly Notes Payables fell 37.07% to $944.0 million in Q4 2019 from the year-ago period, while the trailing twelve-month figure was $944.0 million through Dec 2019, down 37.07% year-over-year, with the annual reading at $944.0 million for FY2019, 37.07% down from the prior year.
  • Notes Payables hit $944.0 million in Q4 2019 for Cigna, down from $1.1 billion in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $1.5 billion in Q4 2018 to a low of $100.0 million in Q4 2017.
  • Historically, Notes Payables has averaged $872.0 million across 3 years, with a median of $967.0 million in 2019.
  • Biggest five-year swings in Notes Payables: skyrocketed 1400.0% in 2018 and later crashed 37.07% in 2019.
  • Year by year, Notes Payables stood at $100.0 million in 2017, then surged by 1400.0% to $1.5 billion in 2018, then tumbled by 37.07% to $944.0 million in 2019.
  • Business Quant data shows Notes Payables for CI at $944.0 million in Q4 2019, $1.1 billion in Q3 2019, and $990.0 million in Q2 2019.